4.6 Article

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease

期刊

AMERICAN JOURNAL OF MEDICINE
卷 127, 期 1, 页码 71-+

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2013.07.038

关键词

Outcome; Predictors; Prevalence; Resistant hypertension

资金

  1. Pfizer, Inc.

向作者/读者索取更多资源

BACKGROUND: Increasingly, apparent treatment-resistant hypertension has been recognized. However, much of the prevalence, predictors, and outcomes are largely unknown, especially in patients with coronary artery disease. METHODS: We evaluated 10,001 patients with coronary artery disease who were enrolled in the Treating to New Targets trial. Apparent treatment-resistant hypertension was defined as blood pressure >= 140 mm Hg despite 3 antihypertensive agents or < 140 mm Hg with >= 4 antihypertensive agents. The primary outcome was major cardiovascular events (composite of fatal coronary heart disease, nonfatal myocardial infarction, resuscitated cardiac arrest, and stroke). RESULTS: Among the 10,001 patients in the trial, 1112 (11.1%) had apparent treatment-resistant hypertension. In a multivariable model adjusting for baseline differences, the treatment-resistant hypertension group had a 64% increase in primary outcome (hazard ratio [HR], 1.64; 95% confidence interval [CI], 1.39-1.94; P <.001), driven by a 69% increase in coronary heart disease death (HR, 1.69; 95% CI, 1.22, 2.34; P = .001) and 73% increase in nonfatal myocardial infarction (HR, 1.73; 95% CI, 1.39-2.16, P <.0001) when compared with the no apparent treatment-resistant hypertension group. In addition, patients with apparent treatment-resistant hypertension had a 71% increase in major coronary event (P <.0001), 45% increase in death (P = .001), 33% increase in heart failure (P = .05), 53% increase in any cardiovascular event (P <.0001), 60% increase in any coronary event (P <.0001), 68% increase in angina (P <.0001), and 51% increase in coronary revascularization (P <.0001) when compared with the no apparent treatment-resistant hypertension group. Results were largely similar whether the definition of apparent treatment-resistant hypertension was based on a blood pressure >= 140 mm Hg despite 3 agents or a blood pressure < 140 mm Hg with >= 4 agents. CONCLUSIONS: In patients with coronary artery disease, apparent treatment-resistant hypertension is associated with a marked increase in the risk of cardiovascular morbidity and mortality, including an increase in all-cause death. (C) 2014 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cardiac & Cardiovascular Systems

Myocardial Infarction in the ISCHEMIA Trial Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons

Bernard R. Chaitman, Karen P. Alexander, Derek D. Cyr, Jeffrey S. Berger, Harmony R. Reynolds, Sripal Bangalore, William E. Boden, Renato D. Lopes, Marcin Demkow, Gian Piero Perna, Robert K. Riezebos, Edward O. McFalls, Subhash Banerjee, Akshay Bagai, Gilbert Gosselin, Sean M. O'Brien, Frank W. Rockhold, David D. Waters, Kristian A. Thygesen, Gregg W. Stone, Harvey D. White, David J. Maron, Judith S. Hochman

Summary: The ISCHEMIA trial showed that an initial invasive strategy did not reduce cardiovascular events or all-cause mortality in patients with stable ischemic heart disease. Procedural MI rates were higher with the invasive strategy compared to conservative strategy, with the use of the secondary MI definition.

CIRCULATION (2021)

Review Cardiac & Cardiovascular Systems

Duration of Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement: Systematic Review and Network Meta-Analysis

Toshiki Kuno, Yujiro Yokoyama, Alexandros Briasoulis, Makoto Mori, Masao Iwagami, Tomo Ando, Hisato Takagi, Sripal Bangalore

Summary: This study compared the outcomes of single antiplatelet therapy versus 3- or 6-month DAPT following TAVR. Results showed that the risk of major bleeding was significantly higher in the 3- and 6-month DAPT groups compared to the single antiplatelet therapy group, with similar rates of stroke and all-cause mortality among the three groups.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Article Cardiac & Cardiovascular Systems

Comparison of SYNTAX score strata effects of percutaneous and surgical revascularization trials: A meta-analysis

Mario Gaudino, Irbaz Hameed, Antonino Di Franco, Ajita Naik, Michelle Demetres, Giuseppe Biondi-Zoccai, Sripal Bangalore

Summary: This study conducted a systematic review and meta-analysis to compare the efficacy of percutaneous coronary intervention and coronary artery bypass grafting stratified by SYNTAX score. The results showed no significant association between SYNTAX score and the comparative effectiveness of the two procedures.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2023)

Editorial Material Cardiac & Cardiovascular Systems

Why Are We Still Prescribing Angiotensin-Converting Enzyme Inhibitors?

Franz H. Messerli, Chirag Bavishi, Sripal Bangalore

CIRCULATION (2022)

Article Cardiac & Cardiovascular Systems

Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial

Sripal Bangalore, John A. Spertus, Susanna R. Stevens, Philip G. Jones, G. B. John Mancini, Jonathon Leipsic, Harmony R. Reynolds, Matthew J. Budoff, Cameron J. Hague, James K. Min, William E. Boden, Sean M. O'Brien, Robert A. Harrington, Jeffrey S. Berger, Roxy Senior, Jesus Peteiro, Neeraj Pandit, Leonid Bershtein, Mark A. de Belder, Hanna Szwed, Rolf Doerr, Lorenzo Monti, Khaled Alfakih, Judith S. Hochman, David J. Maron

Summary: The study found that intermediate left main disease (LMD) was associated with cardiovascular events. An invasive strategy can reduce nonprocedural MI and improve angina-related quality of life.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2022)

Article Cardiac & Cardiovascular Systems

Invasive Versus Medical Management in Patients With Chronic Kidney Disease and Non-ST-Segment-Elevation Myocardial Infarction

Monil Majmundar, Gabriel Ibarra, Ashish Kumar, Rajkumar Doshi, Palak Shah, Roxana Mehran, Grant W. Reed, Rishi Puri, Samir R. Kapadia, Sripal Bangalore, Ankur Kalra

Summary: Invasive management is associated with lower mortality and major adverse cardiovascular events in NSTEMI-CKD patients compared to medical management, with minimal increase in in-hospital complications.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Editorial Material Cardiac & Cardiovascular Systems

The State of Coronary Thrombus Aspiration

Sonal Pruthi, Sripal Bangalore

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Article Cardiac & Cardiovascular Systems

Survival After Invasive or Conservative Management of Stable Coronary Disease

Judith S. Hochman, Rebecca Anthopolos, Harmony. R. Reynolds, Sripal Bangalore, Yifan Xu, Sean M. O'Brien, Stavroula Mavromichalis, Michelle Chang, Aira Contreras, Yves Rosenberg, Ruth Kirby, Balram Bhargava, Roxy Senior, Ann Banfield, Shaun G. Goodman, Renato D. Lopes, Radoslaw Pracon, Jose Lopez-Sendon, Aldo Pietro Maggioni, Jonathan D. Newman, Jeffrey S. Berger, Mandeep S. Sidhu, Harvey D. White, Andrea B. Troxel, Robert A. Harrington, William E. Boden, Gregg W. Stone, Daniel B. Mark, John A. Spertus, David J. Maron

Summary: The ISCHEMIA trial compared the outcomes of initial invasive strategy versus initial conservative strategy in patients with chronic coronary disease and moderate or severe ischemia. The trial found no major difference in most outcomes, but there was lower risk of cardiovascular mortality and higher risk of noncardiovascular mortality with the invasive strategy.

CIRCULATION (2023)

Article Cardiac & Cardiovascular Systems

Optimal Hemostatic Band Duration After Transradial Angiography or Intervention: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials

Muhammad Haisum Maqsood, Samir Pancholy, Kristin A. A. Tuozzo, Nicole Moskowitz, Sunil V. V. Rao, Sripal Bangalore

Summary: For patients undergoing transradial access procedures, a hemostasis duration of 2 hours offers the best balance between preventing radial artery occlusion and reducing the risk of access site bleeding or hematoma.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2023)

Letter Cardiac & Cardiovascular Systems

Hospital procedural volume predicts short-term outcomes for patients undergoing procedures requiring large-bore access

Monil Majmundar, Rajkumar Doshi, Rhythm Vasudeva, Kunal N. Patel, Ashish Kumar, Sripal Bangalore, Ankur Kalra

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2023)

Article Cardiac & Cardiovascular Systems

Outcomes With Percutaneous Debulking of Tricuspid Valve Endocarditis

Robert S. Zhang, Usman Alam, Muhammad H. Maqsood, Yuhe Xia, Rafael Harari, Norma Keller, Lindsay Elbaum, Sunil V. Rao, Carlos L. Alviar, Sripal Bangalore

Summary: In this study, percutaneous vegetation debulking was found to be a feasible, effective, and safe treatment option for patients with tricuspid valve infective endocarditis refractory to medical therapy.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2023)

Review Cardiac & Cardiovascular Systems

Short-Term DAPT and DAPT De-Escalation Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

Toshiki Kuno, Atsuyuki Watanabe, Satoshi Shoji, Tomohiro Fujisaki, Hiroki Ueyama, Hisato Takagi, Pierre Deharo, Thomas Cuisset, Sripal Bangalore, Roxana Mehran, Gregg W. Stone, Shun Kohsaka, Deepak L. Bhatt

Summary: In patients with acute coronary syndrome, unguided de-escalation is associated with the lowest risk of major adverse cardiovascular events and major or minor bleeding outcomes, while short DAPT followed by P2Y12 inhibitor is associated with the lowest risk of major bleeding and all-cause death.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2023)

Review Peripheral Vascular Disease

Timing of Antihypertensive Drug Therapy: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Muhammad Haisum Maqsood, Franz H. Messerli, Adam H. Skolnick, Jonathan D. Newman, Jeffrey S. Berger, Sripal Bangalore

Summary: This study compared the efficacy of morning versus evening dosing of antihypertensive drugs and found that evening dosing significantly reduced ambulatory blood pressure parameters and cardiovascular events, but this effect was mainly driven by trials by the Hermida group. Therefore, the timing of antihypertensive drug administration should be chosen based on convenience and minimizing undesirable effects.

HYPERTENSION (2023)

Article Cardiac & Cardiovascular Systems

Mortality in Patients Hospitalized With Acute Myocardial Infarction Without Standard Modifiable Risk Factors: The ARIC Study Community Surveillance

Zainali S. Chunawala, Melissa C. Caughey, Deepak L. Bhatt, Michael Hendrickson, Sameer Arora, Sripal Bangalore, John P. Erwin, Justin P. Levisay, Jonathan R. Rosenberg, Mark J. Ricciardi, Ron Blankstein, Kunihiro Matsushita, Sidney Smith, Arman Qamar

Summary: AMI is not rare among individuals without SMuRFs. The clinical characteristics and prognosis of SMuRFless individuals are not well described. Therefore, personalized prevention and treatment strategies need to be developed for this population.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Cardiac & Cardiovascular Systems

Catheter-based therapy for intermediate or high-risk pulmonary embolism is associated with lower in-hospital mortality in patients with cancer: Insights from the National Inpatient Sample

Orly Leiva, Eugene Yuriditsky, Radu Postelnicu, Eric H. Yang, Vikramjit Mukherjee, Allison Greco, James Horowitz, Carlos Alviar, Sripal Bangalore

Summary: Among cancer patients with intermediate or high-risk PE, treatment with CBT was associated with a lower risk of in-hospital death or cardiac arrest but a higher risk of bleeding.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2023)

暂无数据